VCN BioSciences
VCN Biosciences specializes in the research and development of new treatments for tumors.
Launch date
Employees
Gelida Catalonia (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| Revenues | - | <1m | <1m | <1m | <1m | <1m |
| % growth | - | - | - | (17 %) | (62 %) | 917 % |
| EBITDA | (1.5m) | (1.7m) | (2.8m) | (2.9m) | (3.2m) | (3.0m) |
| % EBITDA margin | - | (17718 %) | (30257 %) | (37555 %) | (109528 %) | (10160 %) |
| Profit | (1.2m) | (1.1m) | (1.5m) | (1.5m) | (1.6m) | (1.8m) |
| % profit margin | - | (11435 %) | (15525 %) | (19390 %) | (53538 %) | (6025 %) |
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Grant | ||
N/A | Spinout | ||
N/A | Grant | ||
| N/A | N/A | - | |
* | N/A | Acquisition | |
| Total Funding | - | ||
Related Content
Recent News about VCN BioSciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.